Riboflavin Corneal Crosslinking Market Projected to Reach USD 385 Million by 2034 at 8.5% CAGR
  Market Overview The global Riboflavin Corneal Crosslinking Market focuses on specialized riboflavin and riboflavin phosphate formulations used in ultraviolet (UV)-activated corneal collagen crosslinking. These formulations support treatments designed to strengthen corneal tissue and help control the progression of conditions such as keratoconus and post-refractive ectasia. According to...
0 Comentários 0 Compartilhamentos 59 Visualizações 0 Anterior